Starting in 2025, Maolac and Salutivia will be bringing Maolac's groundbreaking, scientifically backed, colostrum-based ingredients to the UK and Ireland wellness industry.
This partnership will introduce Maolac's groundbreaking human nutrition and targeted wellness products, including:
- Maolactin FMR ™: Reduces systemic inflammation, aids muscle recovery, and preserves muscle mass
- Maolactin™ GI: Targets gut health and holistic gut protection
- Super Colostrum: Supports overall health and wellbeing
Maolac colostrum ingredients offer unique benefits:
- Sourced from 'transition milk', ensuring calf welfare
- Freeze-dried to preserve bioactivity
- Derived from EU cows, adhering to high animal welfare standards
- Low effective dosing of 100-360mg
Maya Ashkenazi, Maolac's Founder and CEO, shared: "We're thrilled about this agreement and confident that Salutivia's expertise in specialty innovative ingredients will help us reach new heights."
Earle Logan Business Manager at Salutivia said: "We are so excited about this partnership. Maolac's AI - driven research has identified specific peptides that target areas of concern in human health and wellbeing. We can now consider 'speaking' to our own physiology to restore well-being, a pivot which is a true revolution in the field of nutrition. Maolac have also overcome the ethical, dosage and sensory barriers that have held back generic colostrum for so long. Huge congratulations to them.”
This partnership will introduce Maolac's groundbreaking human nutrition and targeted wellness products, including:
- Maolactin FMR ™: Reduces systemic inflammation, aids muscle recovery, and preserves muscle mass
- Maolactin™ GI: Targets gut health and holistic gut protection
- Super Colostrum: Supports overall health and wellbeing
Maolac colostrum ingredients offer unique benefits:
- Sourced from 'transition milk', ensuring calf welfare
- Freeze-dried to preserve bioactivity
- Derived from EU cows, adhering to high animal welfare standards
- Low effective dosing of 100-360mg
Maya Ashkenazi, Maolac's Founder and CEO, shared: "We're thrilled about this agreement and confident that Salutivia's expertise in specialty innovative ingredients will help us reach new heights."
Earle Logan Business Manager at Salutivia said: "We are so excited about this partnership. Maolac's AI - driven research has identified specific peptides that target areas of concern in human health and wellbeing. We can now consider 'speaking' to our own physiology to restore well-being, a pivot which is a true revolution in the field of nutrition. Maolac have also overcome the ethical, dosage and sensory barriers that have held back generic colostrum for so long. Huge congratulations to them.”